Q92731 | SWISS-MODEL Repository

Q92731 (ESR2_HUMAN) Homo sapiens (Human)

Estrogen receptor beta UniProtKB InterPro STRING Interactive Modelling

530 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3; Isoform 4; Isoform 5; Isoform 6; Isoform 7; Isoform 8; Isoform 9); 1 identical sequence: Homo sapiens: Q7LCB3

It is possible new templates exist for this target since these models were created.

Available Structures

37 Experimental Structures

Description	PDB ID	Oligo-state	Range	Ligands
HUMAN ESTROGEN RECEPTOR BETA LIGAND-BINDING DOMAIN IN COMPLEX WITH KB095285 AND CIA12 COACTIVATOR P…	4zi1 SMTL PDBe PDBe-KB PDBj PDBsum RCSB	Heteromer Q9HCD5;	262-502	2×KB0;
Assess
Crystal Structure of Estrogen Receptor beta complexed with WAY-338	1u3r SMTL PDBe PDBe-KB PDBj PDBsum RCSB	Heteromer Q15788;	263-501	2×338;
Assess
Crystal Structure of Estrogen Receptor Beta Complexed with WAY-555	2nv7 SMTL PDBe PDBe-KB PDBj PDBsum RCSB	Heteromer Q15788;	263-500	2×555;
Assess
Crystal structure of estrogen receptor beta complexed with 3-Bromo-6-hydroxy-2-(4-hydroxy-phenyl)-i…	1zaf SMTL PDBe PDBe-KB PDBj PDBsum RCSB	Heteromer Q15788;	263-500	2×789;
Assess
Crystal structure of phosphorylated estrogen receptor beta ligand binding domain	3oll SMTL PDBe PDBe-KB PDBj PDBsum RCSB	Heteromer Q15788;	262-498	1×EST;
Assess
Human Estrogen Receptor beta Ligand-binding Domain in Complex with S-DPN	7xvy SMTL PDBe PDBe-KB PDBj PDBsum RCSB	Heteromer Q15788;	263-498	2×I0K;
Assess
Human Estrogen Receptor beta Ligand-binding Domain in Complex with (R)-2-(2-chloro-4-hydroxyphenyl)…	7xwq SMTL PDBe PDBe-KB PDBj PDBsum RCSB	Heteromer Q15788;	263-498	2×I1M;
Assess
Human Estrogen Receptor beta Ligand-binding Domain in Complex with (S)-3-(2-chloro-4-hydroxyphenyl)…	7xwp SMTL PDBe PDBe-KB PDBj PDBsum RCSB	Heteromer Q15788;	263-498	2×I1I;
Assess
Human Estrogen Receptor beta Ligand-binding Domain in Complex with (R)-3-(2-chloro-4-hydroxyphenyl)…	7xvz SMTL PDBe PDBe-KB PDBj PDBsum RCSB	Heteromer Q15788;	263-498	2×I1D;
Assess
Human Estrogen Receptor beta Ligand-binding Domain in Complex with (S)-2-(2-chloro-4-hydroxyphenyl)…	7xwr SMTL PDBe PDBe-KB PDBj PDBsum RCSB	Heteromer Q15788;	263-498	2×I2B;
Assess
Stapled peptide bound to Estrogen Receptor Beta	2yjd SMTL PDBe PDBe-KB PDBj PDBsum RCSB	Heteromer Q15596;	263-497	2×YJD;
Assess
CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH WAY-697	1x76 SMTL PDBe PDBe-KB PDBj PDBsum RCSB	Heteromer Q15788;	263-497	2×697;
Assess
Crystal Structure of Estrogen Receptor beta complexed with WAY-797	1u3s SMTL PDBe PDBe-KB PDBj PDBsum RCSB	Heteromer Q15788;	263-497	2×797;
Assess
Crystal structure of estrogen receptor beta complexed with 1-chloro-6-(4-hydroxy-phenyl)-naphthalen…	1yy4 SMTL PDBe PDBe-KB PDBj PDBsum RCSB	Heteromer Q15788;	263-497	2×4NA;
Assess
Fragment-Based Design of novel Estrogen Receptor Ligands	3omq SMTL PDBe PDBe-KB PDBj PDBsum RCSB	Heteromer Q15788;	264-497	1×W23;
Assess
Fragment-Based Design of novel Estrogen Receptor Ligands	3omp SMTL PDBe PDBe-KB PDBj PDBsum RCSB	Heteromer Q15788;	264-497	1×W14;
Assess
Crystal structure of estrogen receptor beta ligand binding domain	3ols SMTL PDBe PDBe-KB PDBj PDBsum RCSB	Heteromer Q15788;	264-497	1×EST;
Assess
Fragment-Based Design of novel Estrogen Receptor Ligands	3omo SMTL PDBe PDBe-KB PDBj PDBsum RCSB	Heteromer Q15788;	264-497	1×WV7;
Assess
A second binding site for hydroxytamoxifen within the coactivator-binding groove of estrogen recept…	2fsz SMTL PDBe PDBe-KB PDBj PDBsum RCSB	homo-2-mer	260-501	4×OHT;
Assess
Estrogen receptor beta ligand binding domain in complex with a Benzopyran agonist	2jj3 SMTL PDBe PDBe-KB PDBj PDBsum RCSB	homo-2-mer	260-501	2×JJ3;
Assess
HUMAN OESTROGEN RECEPTOR BETA LIGAND-BINDING DOMAIN IN COMPLEX WITH PARTIAL AGONIST GENISTEIN	1qkm SMTL PDBe PDBe-KB PDBj PDBsum RCSB	homo-2-mer	260-500	2×GEN;
Assess
Human estrogen receptor beta ligand-binding domain in complex with compound 45	2giu SMTL PDBe PDBe-KB PDBj PDBsum RCSB	homo-2-mer	260-500	2×FBR;
Assess
Estrogen receptor beta ligand-binding domain complexed to a benzopyran ligand	2z4b SMTL PDBe PDBe-KB PDBj PDBsum RCSB	homo-2-mer	260-500	2×DC8;
Assess
Estrogen receptor beta ligand-binding domain complexed to a benzopyran ligand	2qtu SMTL PDBe PDBe-KB PDBj PDBsum RCSB	homo-2-mer	260-500	2×3AS;
Assess
Crystal Structure of ER beta bound to Estradiol	5toa SMTL PDBe PDBe-KB PDBj PDBsum RCSB	homo-2-mer	262-501	2×EST;
Assess
Benzopyrans are Selective Estrogen Receptor beta Agonists (SERBAs) with Novel Activity in Models of…	2i0g SMTL PDBe PDBe-KB PDBj PDBsum RCSB	homo-2-mer	260-498	2×I0G;
Assess
Sulfonamides as selective Estrogen Receptor beta Agonists.	2yly SMTL PDBe PDBe-KB PDBj PDBsum RCSB	homo-2-mer	260-498	2×SU4; 2×SO4;
Assess
Crystal structure of estrogen receptor beta complexed with way-202196	1yye SMTL PDBe PDBe-KB PDBj PDBsum RCSB	homo-2-mer	263-500	2×196;
Assess
CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH WAY-244	1x78 SMTL PDBe PDBe-KB PDBj PDBsum RCSB	homo-2-mer	263-500	2×244;
Assess
CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH ERB-041	1x7b SMTL PDBe PDBe-KB PDBj PDBsum RCSB	homo-2-mer	263-500	2×041;
Assess
CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH GENISTEIN	1x7j SMTL PDBe PDBe-KB PDBj PDBsum RCSB	homo-2-mer	263-497	2×GEN;
Assess
Crystal Structure of Estrogen Receptor beta complexed with CL-272	1u3q SMTL PDBe PDBe-KB PDBj PDBsum RCSB	homo-2-mer	263-497	2×272;
Assess
Human Estrogen Receptor beta Ligand-binding Domain in Complex with (R,R)-5,11-cis-diethyl-5,6,11,12…	1l2j SMTL PDBe PDBe-KB PDBj PDBsum RCSB	monomer	261-501	1×ETC;
Assess
Estrogen Receptor beta with Selective Triazine Modulator	1nde SMTL PDBe PDBe-KB PDBj PDBsum RCSB	monomer	261-500	1×MON;
Assess
Estrogen Receptor in complex with proline-flanked LXXLL peptides	4j26 SMTL PDBe PDBe-KB PDBj PDBsum RCSB	monomer	261-498	1×EST;
Assess
Estrogen Receptor in complex with proline-flanked LXXLL peptides	4j24 SMTL PDBe PDBe-KB PDBj PDBsum RCSB	monomer	262-498	1×EST;
Assess
CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH WAY-397	1u9e SMTL PDBe PDBe-KB PDBj PDBsum RCSB	monomer	263-497	1×397;
Assess

15 SWISS-MODEL models

Template	Oligo-state	QMEANDisCo	Range	Ligands	Trg-Tpl Seq id (%)
7prw.1.B	monomer	0.61	146-500	2×ZN;	30.21
Assess
7prw.1.A	monomer	0.60	143-500	2×ZN;	30.21
Assess
7wnh.4.A	monomer	0.60	149-498	1×ZN;	26.71
Assess
7wnh.2.A	monomer	0.60	148-495	2×ZN;	26.71
Assess
5uan.1.B	monomer	0.59	148-496	1×ZN;	27.40
Assess
7kw7.1.F	monomer	0.59	253-501		30.21
Assess
4nqa.1.A	monomer	0.58	147-496	2×ZN;	34.88
Assess
5uan.1.A	monomer	0.58	147-497	1×ZN;	32.93
Assess
4nqa.2.A	monomer	0.58	142-498	1×ZN;	32.93
Assess
4nqa.2.B	monomer	0.58	144-497	2×ZN;	25.58
Assess
4iqr.1.B	monomer	0.57	147-497	2×ZN;	29.15
Assess
4iqr.1.A	monomer	0.57	147-497	2×ZN;	29.15
Assess
3dzy.1.A	monomer	0.57	146-495	2×ZN;	32.42
Assess
4nqa.1.B	monomer	0.57	144-496	1×ZN;	25.58
Assess
3dzu.1.B	monomer	0.55	146-497		23.10
Assess

Model ID	Oligo-state	Avg pLDDT	Range	Trg-Mdl Seq Id (%)

Model ID	Oligo-state	Avg Confidence	Range	Trg-Mdl Seq id (%)

94 SWISS-MODEL models built on isoform sequence

Template	Isoform	Oligo-state	QMEANDisCo	Range	Ligands	Trg-Tpl Seq id (%)
Isoform 2	7prw.1.A	monomer	0.60	143-477	2×ZN;	31.76
Assess
Isoform 2	7kw7.1.F	monomer	0.59	253-477		31.86
Assess
Isoform 2	7prw.1.B	monomer	0.59	146-477	2×ZN;	31.76
Assess
Isoform 2	5uan.1.B	monomer	0.59	148-490	1×ZN;	26.99
Assess
Isoform 2	7wnh.2.A	monomer	0.58	148-491	2×ZN;	26.36
Assess
Isoform 2	7wnh.4.A	monomer	0.58	149-491	1×ZN;	26.36
Assess
Isoform 2	4nqa.1.A	monomer	0.58	142-490	2×ZN;	31.37
Assess
Isoform 2	4iqr.2.A	monomer	0.58	147-491	2×ZN;	29.62
Assess
Isoform 2	3e00.1.A	monomer	0.57	146-490	2×ZN;	30.82
Assess
Isoform 2	5uan.1.A	monomer	0.57	147-490	1×ZN;	31.37
Assess
Isoform 2	4iqr.2.B	monomer	0.56	147-491	2×ZN;	29.62
Assess
Isoform 2	4nqa.2.B	monomer	0.56	143-491	2×ZN;	25.07
Assess
Isoform 2	4nqa.1.B	monomer	0.55	143-491	1×ZN;	25.07
Assess
Isoform 2	3dzu.1.B	monomer	0.55	146-491		23.88
Assess
Isoform 3	5uan.1.B	monomer	0.55	149-321	1×ZN;	36.31
Assess
Isoform 3	7prw.1.A	monomer	0.54	143-322	2×ZN;	35.67
Assess
Isoform 3	3dzy.1.A	monomer	0.53	146-322	2×ZN;	33.75
Assess
Isoform 3	4iqr.2.B	monomer	0.52	147-322	2×ZN;	31.41
Assess
Isoform 3	7prw.1.B	monomer	0.52	146-322	2×ZN;	35.67
Assess
Isoform 3	4iqr.2.A	monomer	0.51	147-322	2×ZN;	31.41
Assess
Isoform 4	7prw.1.A	monomer	0.61	143-478	2×ZN;	31.86
Assess
Isoform 4	7wnh.4.A	monomer	0.60	149-483	1×ZN;	28.35
Assess
Isoform 4	5uan.1.B	monomer	0.59	148-482	1×ZN;	26.73
Assess
Isoform 4	7wnh.2.A	monomer	0.59	148-483	2×ZN;	28.35
Assess
Isoform 4	7prw.1.B	monomer	0.59	146-478	2×ZN;	31.86
Assess
Isoform 4	7kw7.1.F	monomer	0.59	253-481		32.19
Assess
Isoform 4	4nqa.2.B	monomer	0.57	143-482	2×ZN;	26.14
Assess
Isoform 4	4iqr.2.A	monomer	0.57	147-480	2×ZN;	28.48
Assess
Isoform 4	5uan.1.A	monomer	0.57	147-483	1×ZN;	32.17
Assess
Isoform 4	4nqa.2.A	monomer	0.57	142-483	1×ZN;	32.17
Assess
Isoform 4	3dzy.1.A	monomer	0.57	146-483	2×ZN;	31.61
Assess
Isoform 4	3dzy.1.B	monomer	0.57	146-474	1×ZN;	23.20
Assess
Isoform 4	4nqa.1.B	monomer	0.56	143-482	1×ZN;	26.14
Assess
Isoform 4	4iqr.1.B	monomer	0.56	147-480	2×ZN;	28.48
Assess
Isoform 5	7prw.1.A	monomer	0.60	143-476	2×ZN;	31.65
Assess
Isoform 5	7wnh.4.A	monomer	0.59	149-475	1×ZN;	27.71
Assess
Isoform 5	7wnh.2.A	monomer	0.59	148-475	2×ZN;	27.71
Assess
Isoform 5	7kw7.1.F	monomer	0.59	253-475		31.75
Assess
Isoform 5	7prw.1.B	monomer	0.59	146-476	2×ZN;	31.65
Assess
Isoform 5	3dzu.1.A	monomer	0.59	147-407	2×ZN;	37.30
Assess
Isoform 5	4nqa.2.B	monomer	0.57	143-474	2×ZN;	24.84
Assess
Isoform 5	5uan.1.B	monomer	0.57	149-480	1×ZN;	29.51
Assess
Isoform 5	4iqr.1.A	monomer	0.57	147-474	2×ZN;	29.29
Assess
Isoform 5	3dzy.1.B	monomer	0.56	146-476	1×ZN;	23.36
Assess
Isoform 5	4nqa.1.A	monomer	0.56	147-407	2×ZN;	37.30
Assess
Isoform 5	4nqa.1.B	monomer	0.56	143-474	1×ZN;	24.84
Assess
Isoform 5	4iqr.1.B	monomer	0.56	147-474	2×ZN;	29.29
Assess
Isoform 5	5uan.1.A	monomer	0.56	147-407	1×ZN;	37.30
Assess
Isoform 6	7prw.1.A	monomer	0.61	143-470	2×ZN;	32.26
Assess
Isoform 6	5uan.1.B	monomer	0.60	148-470	1×ZN;	27.12
Assess
Isoform 6	7wnh.4.A	monomer	0.60	149-470	1×ZN;	27.83
Assess
Isoform 6	7wnh.2.A	monomer	0.60	148-470	2×ZN;	27.83
Assess
Isoform 6	7prw.1.B	monomer	0.60	146-470	2×ZN;	32.26
Assess
Isoform 6	4iqr.2.A	monomer	0.58	147-470	2×ZN;	29.35
Assess
Isoform 6	4nqa.2.A	monomer	0.58	142-470	1×ZN;	32.45
Assess
Isoform 6	4iqr.2.B	monomer	0.58	147-470	2×ZN;	29.35
Assess
Isoform 6	4nqa.2.B	monomer	0.58	143-470	2×ZN;	25.47
Assess
Isoform 6	3dzy.1.A	monomer	0.57	146-470	2×ZN;	32.23
Assess
Isoform 6	5uan.1.A	monomer	0.57	147-470	1×ZN;	32.45
Assess
Isoform 6	4nqa.1.B	monomer	0.57	143-470	1×ZN;	25.47
Assess
Isoform 6	3dzu.1.B	monomer	0.56	146-470		23.49
Assess
Isoform 6	7kw7.1.F	monomer	0.55	248-408		37.21
Assess
Isoform 7	7wnh.4.A	monomer	0.54	149-407	1×ZN;	26.56
Assess
Isoform 7	4nqa.2.B	monomer	0.52	144-406	2×ZN;	27.38
Assess
Isoform 7	4nqa.1.A	monomer	0.52	142-405	2×ZN;	31.87
Assess
Isoform 7	4nqa.1.B	monomer	0.52	144-405	1×ZN;	27.38
Assess
Isoform 7	7wnh.2.A	monomer	0.51	148-404	2×ZN;	26.56
Assess
Isoform 7	7prw.1.A	monomer	0.51	143-411	2×ZN;	28.46
Assess
Isoform 7	3dzu.1.A	monomer	0.51	146-404	2×ZN;	32.11
Assess
Isoform 8	7wnh.3.A	monomer	0.58	148-364	1×ZN;	32.86
Assess
Isoform 8	7wnh.2.A	monomer	0.56	148-364	2×ZN;	32.86
Assess
Isoform 8	7prw.1.A	monomer	0.55	143-365	2×ZN;	36.15
Assess
Isoform 8	4nqa.1.B	monomer	0.55	144-364	1×ZN;	28.96
Assess
Isoform 8	4nqa.2.B	monomer	0.54	144-364	2×ZN;	28.96
Assess
Isoform 8	4iqr.2.B	monomer	0.54	147-365	2×ZN;	33.67
Assess
Isoform 8	7prw.1.B	monomer	0.54	148-363	2×ZN;	38.65
Assess
Isoform 8	3dzu.1.B	monomer	0.53	146-362		26.73
Assess
Isoform 8	4iqr.2.A	monomer	0.53	147-365	2×ZN;	33.67
Assess
Isoform 8	3dzy.1.A	monomer	0.51	147-371	2×ZN;	39.61
Assess
Isoform 8	4nqa.1.A	monomer	0.51	147-371	2×ZN;	40.10
Assess
Isoform 9	7prw.1.B	monomer	0.61	146-473	2×ZN;	32.17
Assess
Isoform 9	7prw.1.A	monomer	0.61	143-473	2×ZN;	32.17
Assess
Isoform 9	5uan.1.B	monomer	0.60	148-472	1×ZN;	26.54
Assess
Isoform 9	7wnh.2.A	monomer	0.60	148-471	2×ZN;	28.06
Assess
Isoform 9	7wnh.4.A	monomer	0.60	149-471	1×ZN;	28.06
Assess
Isoform 9	3dzu.1.A	monomer	0.59	147-407	2×ZN;	37.30
Assess
Isoform 9	7kw7.1.F	monomer	0.59	253-473		31.63
Assess
Isoform 9	4iqr.2.A	monomer	0.58	147-472	2×ZN;	29.15
Assess
Isoform 9	4nqa.2.B	monomer	0.58	143-471	2×ZN;	26.02
Assess
Isoform 9	4nqa.1.A	monomer	0.57	147-407	2×ZN;	37.30
Assess
Isoform 9	5uan.1.A	monomer	0.57	147-407	1×ZN;	37.30
Assess
Isoform 9	4iqr.2.B	monomer	0.57	147-472	2×ZN;	29.15
Assess
Isoform 9	4nqa.1.B	monomer	0.57	143-471	1×ZN;	26.02
Assess
Isoform 9	3dzu.1.B	monomer	0.56	146-471		23.42
Assess

Q92731 (ESR2_HUMAN) Homo sapiens (Human)

Estrogen receptor beta UniProtKBInterProSTRINGInteractive Modelling

Available Structures

37 Experimental Structures

15 SWISS-MODEL models

94 SWISS-MODEL models built on isoform sequence

Alignments

Background

Resolution

Estrogen receptor beta UniProtKB InterPro STRING Interactive Modelling